Jorg J. A. Calis

3.2k citations

24 papers · 2.1k indexed · 3 hit papers · h-index 13

Molecular Biology top 5%
Immunology top 2%
Oncology top 5%
Radiology, Nuclear Medicine and Imaging top 5%
Epidemiology

Co-authors: Can Keşmir Brad R. Rosenberg Aruna Dharshan De Silva Jason Greenbaum Bjoern Peters Daniela Weiskopf Alessandro Sette Ton N. Schumacher
Topics: Immunotherapy and Immune Responses (8 papers)T-cell and B-cell Immunology (6 papers)vaccines and immunoinformatics approaches (5 papers)
Cited by: Immunology Transplantation Oncology
Journals: Cell Nature MedicineSHILAP Revista de lepidopterología
Partner nations: Netherlands United States Germany

In The Last Decade

Jorg J. A. Calis

21 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Properties of MHC Class I Presented Peptides That Enhance Immunogenicity

2013 623 citations Jorg J. A. Calis, Jason Greenbaum et al. PLoS Computational Biology profile →
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

2014 527 citations Carsten Linnemann, Marit M. van Buuren et al. Nature Medicine profile →
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown

2018 378 citations Hachung Chung, Jorg J. A. Calis et al. Cell profile →

Peers

Countries citing papers authored by Jorg J. A. Calis

Since Specialization

Citations

This map shows the geographic impact of Jorg J. A. Calis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorg J. A. Calis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorg J. A. Calis more than expected).

Fields of papers citing papers by Jorg J. A. Calis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorg J. A. Calis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorg J. A. Calis. The network helps show where Jorg J. A. Calis may publish in the future.

Co-authorship network of co-authors of Jorg J. A. Calis

This figure shows the co-authorship network connecting the top 25 collaborators of Jorg J. A. Calis. A scholar is included among the top collaborators of Jorg J. A. Calis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorg J. A. Calis. Jorg J. A. Calis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nicotinamide Inhibits CD4+ T-Cell Activation and Function 2025 ·Cells ·(unknown),(unknown),Rianne C. Scholman,(unknown),(unknown),Enric Mocholí,(unknown),Jorg J. A. Calis,Michal Mokrý,Sebastiaan J. Vastert,Jorg van Loosdregt	0
2	N6-methyladenosine promotes TNF mRNA degradation in CD4+ T lymphocytes 2024 ·Journal of Leukocyte Biology ·(unknown),(unknown),Rianne C. Scholman,(unknown),(unknown),(unknown),Michal Mokrý,(unknown),Robert Jan Lebbink,Enric Mocholí,Paul J. Coffer,Jorg J. A. Calis,Sebastiaan J. Vastert,Jorg van Loosdregt	2
3	Human Plaque Myofibroblasts to Study Mechanisms of Atherosclerosis 2023 ·Journal of the American Heart Association ·(unknown),Ernest Diez Benavente,Lotte Slenders,(unknown),(unknown),(unknown),(unknown),(unknown),Mark A. Daniëls,(unknown),Jorg J. A. Calis,(unknown),Gert J. de Borst,Dominique P.V. de Kleijn,Gerard Pasterkamp,Hester M. den Ruijter,Michal Mokrý	5
4	N6-Methyladenosine Directly Regulates CD40L Expression in CD4+ T Lymphocytes 2023 ·Biology ·(unknown),(unknown),Rianne C. Scholman,(unknown),Michal Mokrý,(unknown),Robert Jan Lebbink,Jorg J. A. Calis,Sebastiaan J. Vastert,Jorg van Loosdregt	9
5	Recombinant Interleukin‐1 Receptor Antagonist Is an Effective First‐Line Treatment Strategy in New‐Onset Systemic Juvenile Idiopathic Arthritis, Irrespective of HLA‐DRB1 Background and IL1RN Variants 2023 ·Arthritis & Rheumatology ·(unknown),Jorg J. A. Calis,(unknown),Sytze de Roock,Nienke M. ter Haar,(unknown),Lars T. van der Veken,Robert F. Ernst,Hanneke W. M. van Deutekom,(unknown),Rianne C. Scholman,Marc H.A. Jansen,Joost F. Swart,Rashmi Sinha,Johannes Roth,Grant S. Schulert,Alexei A. Grom,Jorg van Loosdregt,Sebastiaan J. Vastert	12
6	Prenatal Sildenafil and Fetal-placental Programming in Human Pregnancies Complicated by Fetal Growth Restriction: A Retrospective Gene Expression Analysis 2023 ·SHILAP Revista de lepidopterología ·(unknown),Torsten Plösch,Jorg J. A. Calis,Wessel Ganzevoort,Anouk Pels,Nina D. Paauw,Sanne J. Gordijn,Bas B. van Rijn,Michal Mokrý,A. Titia Lely	0
7	N6-adenosine methylation (m6A) is involved in the life and death decisions of T cells 2022 ·Cellular and Molecular Immunology ·Jorg J. A. Calis,Jorg van Loosdregt	6
8	Transcriptome of airway neutrophils reveals an interferon response in life-threatening respiratory syncytial virus infection 2020 ·Clinical Immunology ·(unknown),(unknown),Annefleur C Langedijk,Marije P. Hennus,Linde Meyaard,Michal Mokrý,Louis Bont,Jorg J. A. Calis	14
9	Developmental programming in human umbilical cord vein endothelial cells following fetal growth restriction 2020 ·Clinical Epigenetics ·(unknown),Jorg J. A. Calis,Nina D. Paauw,Jaap A. Joles,Bas B. van Rijn,Michal Mokrý,Torsten Plösch,A. Titia Lely	13
10	Exploratory Study of Predicted Indirectly ReCognizable HLA Epitopes in Mismatched Hematopoietic Cell Transplantations 2019 ·Frontiers in Immunology ·Kirsten Geneugelijk,(unknown),Hanneke W. M. van Deutekom,Jorg J. A. Calis,(unknown),Can Keşmir,Machteld Oudshoorn,Bronno van der Holt,Ellen Meijer,Sacha Zeerleder,Marco R. de Groot,Peter A. von dem Borne,Nicolaas Schaap,Jan J. Cornelissen,Jürgen Kuball,Eric Spierings	14
11	Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2Fs 2019 ·Molecular Cell ·Linda Clijsters,Claire Hoencamp,Jorg J. A. Calis,Antonio Marzio,(unknown),Maria C. Cuitiño,Brad R. Rosenberg,Gustavo Leone,Michele Pagano	76
12	Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdownbreakdown → 2018 ·Cell ·Hachung Chung,Jorg J. A. Calis,Xianfang Wu,Tony Sun,Yingpu Yu,Stephanie L. Sarbanes,Viet Loan Dao Thi,(unknown),Hans-Heinrich Hoffmann,Brad R. Rosenberg,Charles M. Rice	378
13	High sensitivity of cancer exome-based CD8 T cell neo-antigen identification 2014 ·OncoImmunology ·Marit M. van Buuren,Jorg J. A. Calis,Ton N. Schumacher	76
14	Role of peptide processing predictions in T cell epitope identification: contribution of different prediction programs 2014 ·Immunogenetics ·Jorg J. A. Calis,Peter Reinink,Christin Keller,Peter M. Kloetzel,Can Keşmir	34
15	Characterizing immune repertoires by high throughput sequencing: strategies and applications 2014 ·Trends in Immunology ·Jorg J. A. Calis,Brad R. Rosenberg	113
16	High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanomabreakdown → 2014 ·Nature Medicine ·Carsten Linnemann,Marit M. van Buuren,Laura Bies,Els M.E. Verdegaal,Remko Schotte,Jorg J. A. Calis,Sam Behjati,Arno Velds,Henk Hilkmann,Dris El Atmioui,Marten Visser,Michael R. Stratton,John B.A.G. Haanen,Hergen Spits,Sjoerd H. van der Burg,Ton N. Schumacher	527
17	Properties of MHC Class I Presented Peptides That Enhance Immunogenicitybreakdown → 2013 ·PLoS Computational Biology ·Jorg J. A. Calis,(unknown),Jason Greenbaum,Daniela Weiskopf,Aruna Dharshan De Silva,Alessandro Sette,Can Keşmir,Bjoern Peters	623
18	Predicted indirectly recognizable HLA epitopes presented by HLA-DR correlate with the de novo development of donor-specific HLA IgG antibodies after kidney transplantation 2012 ·Human Immunology ·Henny G. Otten,Jorg J. A. Calis,Can Keşmir,(unknown),Eric Spierings	80
19	Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire 2012 ·PLoS Computational Biology ·Jorg J. A. Calis,Rob J. de Boer,Can Keşmir	64
20	MHC class I molecules exploit the low G+C content of pathogen genomes for enhanced presentation 2010 ·European Journal of Immunology ·Jorg J. A. Calis,Gabino Sanchez‐Perez,Can Keşmir	11

About Jorg J. A. Calis

Jorg J. A. Calis is a scholar working on Immunology, Transplantation and Oncology, having authored 24 papers that have together received 2.1k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers) and vaccines and immunoinformatics approaches (5 papers). The work is most often cited by research in Immunology (1.2k citations), Transplantation (74 citations) and Oncology (706 citations). Jorg J. A. Calis has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Can Keşmir, Brad R. Rosenberg, Aruna Dharshan De Silva, Jason Greenbaum, Bjoern Peters, Daniela Weiskopf, Alessandro Sette, Ton N. Schumacher, Marit M. van Buuren and Charles M. Rice. Their work appears in journals such as Cell, Nature Medicine and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact